News

CBER is unanimously against Elevdiys’ return to the market without additional evidence, according to media reports citing an ...
In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at the FDA, ...
Sarepta Therapeutics ( NASDAQ: SRPT) faces an “arduous and treacherous path” to bring its gene therapy Elevidys back to ...
Sarepta Therapeutics' recent setbacks and restructuring have pressured Arrowhead's share price. Read why I am reiterating my bullish rating on ARWR stock.
Shares of Sarepta Therapeutics SRPT are declining in the pre-market hours today after the announcement that it will ...
Shares of Sarepta Therapeutics SRPT nosedived 35.9% on Friday following the death of a patient dosed with one of its ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced a strategic restructuring plan ...
Sarepta Therapeutics is laying off 500 staffers, or 36% of its workforce, as part of a strategic restructuring aiming to save $400 million annually. | Sarepta Therapeutics has laid off 500 staffers, ...
People are concerned over changes to gambling deductions and new taxes passed by Congress in the Big Beautiful Bill.
Arrowhead Transit is proud to be hosting the event on Saturday, July 19th. They are grateful to Minnesota North Mesabi Range in Virginia for donating the space of their parking lot for the fun.
At The Track Bite Sized Auto Racing Contest Sam McDowell: If the Chiefs choose to renovate Arrowhead Stadium, here’s when and how ...